Membership
Members' Area
Get Involved
Events
Education
Science policy
Publications
Grants
Awards
About Us

Further reading


 

DDPG in the news


In response to the recent Pfizer takeover bid for Astrazeneca the DDPG released a

letter that highlighted the changing drug discovery landscape in the UK and the effects on the science community. This led to considerable media interaction.  

 

Representatives of the DDPG published

a letter in the Financial Times highlighting the decline of the pharmaceutical industry in the UK. The Association of the British Pharmaceutical Industry (ABPI) published a response to this letter.

 



Further reading

 

Research Fortnight article written by David Phillips: Big pharma is broken, how can we fix it?

Research Fortnight article written by David Fox from the RSC: Keep making the tablets.

 

Research Fortnight article written by Mark Downs, chief executive of the Royal Society of Biology, Drug discoverers must adapt to a more complex world.

 

RSC News article,

Removing boundaries: Enabling the movement of researchers across disciplines and the industry-academia interface.

 

Comments from Mark Downs, chief executive of the Royal Society of Biology, recently featured in the Nature article

AstraZeneca juggernaut heads for Cambridge (£ - pay to view).